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Research
Persistent organic pollutants (POPs) bio­
accumulate through the food chain and may 
cause adverse effects on human health and the 
environment. Main substance classes are poly­
cyclic aromatic hydrocarbons (PAHs), such as 
3­methylcholanthrene (3­MC) and benzo(a)
pyrene [B(a)P], dioxins such as 2,3,7,8­tet­
rachlorodibenzo­p­dioxin (TCDD), and 
polychlorinated biphenyls (PCBs). Because 
of their lipophilicity, POPs cross the human 
placenta, exposing the fetus to the contami­
nant body burden of the mother. This may 
result in adverse health outcomes, includ­
ing effects on central nervous system (CNS) 
develop  ment (reviewed by Wormley et al. 
2004). One potential source for in utero expo­
sure to POPs, especially PAHs, is maternal 
cigarette smoking during pregnancy (Polanska 
et al. 2009; Rodgman et al. 2000). An inverse 
relationship between maternal smoking dur­
ing pregnancy, offspring intelligence (intel­
ligence quotient), and cognitive ability has 
been described in numerous cohort studies 
(Batty et al. 2006; Fried et al. 1998; Olds et al. 
1994). Additionally, behavioral problems and 
psychiatric disorders in offspring have been 
associated with smoking during pregnancy 
(Fergusson et al. 1998; Thapar et al. 2003; 
Weissman et al. 1999). In addition to smok­
ing, in utero exposure to PCBs and/or diox­
ins has been associated with cognitive deficits 
in children (reviewed by Grandjean and 
Landrigan 2006; Jacobson and Jacobson 1997; 
Patandin et al. 1999). It has been proposed 
that etiological mechanisms involve the POP­
activated aryl hydrocarbon receptor (AhR), 
an evolutionary highly conserved member of 
the basic helix­loop­helix/Per­ARNT­Sim 
(bHLH/PAS) family of transcription factors 
(reviewed by Kakeyama and Tohyama 2003). 
Ligand binding to this cytosolic receptor 
induces nuclear translocation (Gasiewicz and 
Bauman 1987) and hetero  dimerization with 
another bHLH/PAS protein, ARNT (AhR 
nuclear translocator) (Reyes et al. 1992). The 
resulting complex recognizes and binds spe­
cific DNA sequences (i.e., dioxin­responsive 
elements) within gene promoter regions and 
modulates subsequent transcription of AhR­
dependent genes (Fujisawa­Sehara et al. 1987). 
Many POPs, including PAHs and dioxins, 
are known AhR ligands and activators of AhR 
signaling. It has therefore been proposed that 
AhR activation causes develop  mental neuro­
toxicity (DNT) (Williamson et al. 2005). This 
hypothesis is supported by studies in inverte­
brate (Caenorhabditis elegans) and vertebrate 
(zebrafish, chicken, rat, monkey) species in 
which dioxins and related compounds cause 
morphological abnormalities of the brain or 
deficits in cognition and/or behavior (Henshel 
et al. 1997; Hill et al. 2003; reviewed by 
Kakeyama and Tohyama 2003; Qin and 
Powell­Coffman 2004). Whether AhR 
activation is the underlying mechanism for the 
reported DNT effects after POP exposure in 
humans is not known.
To investigate potential species­specific dif­
ferences, we employed comparative in vitro 
test systems for brain development based on 
neurosphere cultures from human and mouse 
neural progenitor cells (hNPCs and mNPCs, 
respectively). These three­dimensional cell 
systems mirror basic processes of fetal brain 
development such as proliferation, migration, 
differentiation, and apoptosis. Moreover, they 
detect developmental neurotoxicants in vitro 
(Fritsche et al. 2005; Moors et al. 2007, 2009). 
We report here that, in contrast to wild­type 
mNPCs, hNPCs and AhR­deficient mNPCs 
were insensitive to AhR agonism or antagonism 
due to non  functional AhR signaling, which 
suggests that humans are protected from AhR­
dependent, POP­induced DNT. Knowledge 
about such species­specific differences is of 
utmost importance regarding chemi  cal testing 
and hazard assessment for humans.
Materials and Methods
Chemicals. The AhR antagonist 3´­methoxy­
4´­nitroflavone (MNF) was kindly provided 
by G. Vielhaber (Symrise, Holzminden, 
Germany). Methylmercury chloride (MeHgCl)   
was obtained from Riedel­de Haën (Seelze, 
Germany), and TCDD was purchased from 
LGC Standards (Wesel, Germany). All addi­
tional chemicals used (unless otherwise noted) 
were purchased from Sigma­Aldrich (Munich, 
Germany) and were of the highest purity 
available.
Cell culture. hNPCs used in this study 
were purchased from Lonza Verviers SPRL 
(Verviers, Belgium). Data presented in this 
study are based on experiments conducted 
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Ba c k g r o u n d: Because of their lipophilicity, persistent organic pollutants (POPs) cross the human 
placenta, possibly affecting central nervous system development. Most POPs are known aryl hydro-
carbon receptor (AhR) ligands and activators of AhR signaling. Therefore, AhR activation has been 
suggested to cause develop  mental neurotoxicity (DNT).
oB j e c t i v e: We studied the effects of AhR ligands on basic processes of brain development in two 
comparative in vitro systems to determine whether AhR-activation is the underlying mechanism for 
reported DNT of POPs in humans.
Me t h o d s : We employed neurosphere cultures based on human neural progenitor cells (hNPCs) and 
wild-type and AhR-deficient mouse NPCs (mNPCs) and studied the effects of different AhR agonists 
[3-methylcholanthrene (3-MC), benzo(a)pyrene [B(a)P], and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD)] and an antagonist [3´-methoxy-4´-nitroflavone (MNF)] on neurosphere development. 
Moreover, we analyzed expression of AhR and genes involved in AhR signaling.
re s u l t s: In contrast to wild-type mNPCs, hNPCs and AhR-deficient mNPCs were insensitive to 
AhR agonism or antagonism. Although AhR modulation attenuated wild-type mNPC proliferation 
and migration, hNPCs and AhR-deficient mNPCs remained unaffected. Results also suggest that 
species-specific differences resulted from non  functional AhR signaling in hNPCs.
co n c l u s i o n: Our findings suggest that in contrast to wild-type mNPCs, hNPCs were protected 
against polycyclic aromatic hydrocarbon–induced DNT because of an absence of AhR. This differ-
ence may contribute to species-specific differences in sensitivity to POPs.
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on hNPCs obtained from a single male at 
gestational week 16. Similar results were 
obtained based on hNPCs from a second 
male at gestational week 18. For mouse 
neurosphere cultures, brains of wild­type 
and AhR­knockout (KO) C57/BL6 mice 
(Charles River Laboratories International, 
Wilmington, MA, USA) were removed at 
embryonic day (E) 15.5 (E15.5) to E17.5 
and transferred to phosphate­buffered saline.
Age of the embryos was determined accord­
ing to the staging criteria of Theiler, in 
which E16 correspond to Theiler stage 24 
(Bard et al. 1998). Brains of embryos were 
dissected, transferred to Dulbecco’s modi­
fied Eagle’s medium (DMEM) and mechani­
cally dissociated. Trypsin/EDTA solution was 
added, and the suspension was incubated for 
30 min at 37°C in a humidified atmosphere. 
Afterward, the tissue suspension was tritu­
rated to obtain a single­cell suspension, which 
was centrifuged at 800 rpm for 5 min. Pellets 
were resuspended and plated in 10­cm petri 
dishes. AhR deficiency of mice (Fritsche et al. 
2007) was confirmed by polymerase chain 
reaction (PCR). Data for wild­type mNPC 
were derived from four independent prepara­
tions, and data for AhR­deficient mNPCs 
were obtained from two different prepara­
tions. The animals were treated humanely and 
with regard for alleviation of suffering.
Both hNPCs and mNPCs were cultured 
in proliferation medium [DMEM and Hams 
F12 (3:1) supplemented with B27 (Invitrogen 
GmBH, Karlsruhe, Germany), 20 ng/mL 
epidermal growth factor (EGF; Biosource, 
Karlsruhe, Germany), 20 ng/mL recombinant 
human fibroblast growth factor (FGF; R&D 
Systems, Wiesbaden­Nordenstadt, Germany), 
100 U/mL penicillin, and 100 µg/mL strepto­
mycin] in a humidified 92.5% air/7.5% CO2 
incubator at 37°C in suspension culture.   
Differentiation was initiated by growth fac­
tor withdrawal in differentiation medium 
[DMEM and Hams F12 (3:1) supplemented 
with N2 (Invitrogen), 100 U/mL penicillin, 
and 100 µg/mL streptomycin] and plating 
onto poly­d­lysine (PDL)/laminin–coated 
chamber slides.
Cell viability. We measured cell viability 
using a lactate dehydrogenase (LDH) assay 
(CytoTox­One; Promega, Madison, WI, 
USA) according to the manufacturer’s instruc­
tions. Briefly, supernatants of treated cells 
from the migration, mRNA expression, and 
proliferation assessments were collected at the 
respective time points and incubated 2:1 with 
the CytoTox­One reagent for 4 hr prior to 
detection of fluorescence (excitation, 540 nm; 
emission, 590 nm). Complete lysis of cells 
with the included lysis buffer for 2 hr at room 
temperature served as a positive control.
Proliferation assays, cell cycle analyses, and 
migration assay. Proliferation was assessed 
with a combination of CellTiter­Blue Assay 
(Promega), which measures mitochondrial 
reductase activity, and microscopic determina­
tion of sphere diameter as described previously 
(by Moors et al. 2009). We analyzed cell cycle 
by fluorescence­activated cell sorting (FACS). 
Therefore, neurospheres were exposed to the 
different chemicals for 48 hr, dis  sociated to 
single cells with Accutase, fixed with paraform­
aldehyde, and stained with propidium iodine 
(Moors et al. 2009). Spheres cultured in pro­
liferation medium with 20 ng/mL EGF and 
FGF served as positive controls, and spheres 
cultured without these growth factors served 
as negative controls. Migration distance was 
measured microscopically after 48 hr as previ­
ously described by Moors et al. (2007, 2009). 
Spheres exposed to 1 µM MeHgCl for 48 hr 
served as positive controls.
Quantitative real-time PCR. NPCs were 
treated under differentiating conditions with 
10 µM 3­MC or 1 nM TCDD, or with 0.1% 
dimethyl sulfoxide (DMSO) as the solvent 
control. After indicated time points, RNA was 
prepared with the Absolutely RNA Microprep 
Kit (Stratagene, La Jolla, CA, USA) accord­
ing to the manufacturer’s instructions. Real­
time reverse­transcriptase PCR (RT­PCR) 
was performed using LightCycler instru­
mentation (Roche, Mannheim, Germany) 
with QuantiTect SYBR green PCR Master 
Mix (Qiagen, Hilden, Germany) as pre­
viously described (Fritsche et al. 2007). 
Conditions for PCR amplifications were as 
follows: initial 15 min at 95°C; 40 cycles of 
15 sec at 94°C for denaturation, 25 sec of 
primer annealing, 30 sec at 72°C for elon­
gation; and 2 sec at 72°C for fluorescence 
detection. Intron­spanning primers were 
designed using PRIMER 3 Software (Rozen 
and Skaletsky 2000) to reduce genomic 
amplification. Primer sequences for human 
ACTB (hACTB), hAhR, hAhR repressor 
(hAhRR), human cytochrome P450 1A1 
(hCYP1A1), and hCYP1B1 were described 
by Fritsche et al. (2005). Other primer 
sequences are as follows: hARNT, forward 
(F), CCCTAGTCTCACCAATCGTGGAT; 
reverse  (R),  GTAGCTGT  TGCTCT 
GATCTC  CCAG;   hC-MYC,  F , 
ACCAC  CAGCAGCGACTCTGA; R , 
TCCAGCAGAAGGTGATCCAGACT 
(56°C annealing); mouse Actb (msActb), 
F,  CTACAATGAGCTGCGTGTGG; 
R,  TAGCTCTTCTCCAGGGAGGA 
(60°C  annealing);   msAhR,  F , 
GACAGTTTTCCGGCTTCTTG; R , 
CGCTTCTGTAAATGCTCTCGT 
(60°C  annealing);  msArnt, F , 
TGCCTCATCTGGTACTGCTG; 
R,  GAACATGCTGCTCACTGGAA 
(58°C  annealing);  msAhRR, F , 
GTTGGATCCTGTAGGGAGCA; 
R,  AGACCAGAGGCTCACGCTTA 
(60°C  annealing);  msCyp1a1, F , 
GGCCACTTTGACCCTTACAA; 
R,  CAGGTAACGGAGGACAGGAA 
(54°C  annealing);  msCyp1b1, F , 
ACATGAGTTTCAGTTATGGCC; 
R,  TTCCATTCACTGCTGAGAGC 
(58°C  annealing);  msc-myc, F , 
TGTCCATTCAAGCAGACG; R , 
GCATTTTAATTCCAGCGCATAG (54°C 
annealing). Expression levels were normal­
ized to the expression of β­actin. We evalu­
ated gene expression using the cycle threshold 
(Ct) value from each sample. Calculations 
are based on the ΔΔCt method (Livak and 
Schmittgen 2001). For determining abso­
lute copy numbers, we used product­specific 
standards amplified from cDNA to generate 
standard curves. A target gene was consid­
ered to be quantifiable if the ratio of the copy 
number target gene to the copy number for 
β­actin × 1,000 exceeded 0.001.
Western blotting. Proteins were isolated 
from hNPC or HepG2 human hepato  cellular 
liver carcinoma cells as described by Moors 
et al. (2007). Whole­cell lysates (40 µg) were 
separated by 10% SDS­PAGE and transferred 
to an Amersham Hybond­P­membrane (GE 
Healthcare, Chalfont St. Giles, UK). The 
membrane was blocked in Tris­buffered saline 
containing 0.01% Triton (vol/vol) and 5% 
non  fat dry milk (wt/vol) for 1 hr at room 
temperature, followed by incubation in the 
same buffer containing a polyclonal anti­
AhR antibody (1:2,000; Enzo Life Sciences, 
Loerrach, Germany) or an anti­GAPDH anti­
body (1:100,000; Biozol, Eching, Germany) 
overnight at 4°C. As secondary antibodies we 
used enhanced   chemiluminescence (ECL) anti­
rabbit IgG or ECL anti­mouse IgG horseradish 
peroxidase–linked antibodies (both 1:5,000; 
GE Healthcare). Chemiluminescence signals 
were detected with X­ray film.
Statistics. All results are presented as 
mean ± SEM of at least two independent 
experiments. We used analysis of variance 
combined with Dunnett’s post hoc test for 
multi  factor analyses (concentration effects), 
and Student’s t­test for two­group compari­
sons (treatment vs. control). Significance was 
set at p < 0.05 (Hays 1994).
Results
AhR agonism or antagonism does not cause 
cytotoxicity in hNPCs and mNPCs. Cells were 
exposed to the AhR agonists 3­MC (10 µM; a 
synthetic model compound for AhR­activating 
metabolized PAH), B(a)P (10 µM; a metabo­
lized, environmentally relevant PAH), TCDD 
(1 nM; a non  metabolized, environmentally 
relevant PAH), or the AhR antagonist MNF 
(1 µM; model compound). We treated hNPCs 
and mNPCs for 6, 12, 24, or 48 hr (differen­
tiation conditions). hNPCs were also treated 
for up to 14 days and mNPCs were treated for Species-specific AhR-mediated developmental toxicity
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up to 7 days under proliferation conditions. 
Exposure times for cytotoxicity assays thereby 
correspond to the duration of treatments in 
the proliferation, migration, and gene expres­
sion assays. We chose concentrations based on 
known AhR activation/antagonism in other 
cell types. None of the exposures induced 
cyto  toxicity (LDH release) in hNPCs or 
mNPCs [see Supplemental Material, Figure 1 
(doi:10.1289/ehp.0901545)].
Proliferation of mNPCs, but not hNPCs, 
is inhibited by AhR blockage. Figure 1A and 
B shows quantification of the proliferation 
assays (sphere diameter and CellTiter­Blue 
Assay, respectively) of human neurospheres 
after exposure to 1 and 10 µM 3­MC, 1 nM 
TCDD, or 1 µM MNF. We found no signifi­
cant disparities in prolifera  tion among cells 
with different exposures after 7 or 14 days. 
We verified this using hNPCs derived from 
a second individual (data not shown). The 
average diameter of the human neurospheres 
(excluding the negative controls cultured 
without growth factors) increased from 
444 µm ± 15 µm to 653 µm ± 33 µm (at 
7 days) and 829 µm ± 17 µm (at 14 days). 
The lack of exposure effects on proliferation 
was confirmed by FACS analyses for DNA 
content using propidium iodine staining 
(Figure 1C). We found a cell cycle distribu­
tion typical of proliferating cells in approxi­
mately 2.5% of all NPCs, as described 
previously (Moors et al. 2009). After 48 hr 
of exposure, most proliferating cells were in 
G0/G1­phase (53.5% ± 3.4%), whereas 28% 
± 1.8% were in S­phase, and 18.4% ± 2.8% 
cells were in G2/M­phase, independent of 
exposure conditions.
We monitored proliferation of mNPCs 
over only 7 days because of a size­restricted 
halt in sphere growth beyond that time. In 
contrast to the hNPCs, we observed significant 
inhibition of mNPC proliferation after 7 days 
of exposure to 1 µM MNF. Although con­
trol spheres and 3­MC– and TCDD­exposed 
spheres grew from an average diameter of 
386 µm ± 23 µm to 551 µm ± 85 µm, MNF­
exposed spheres remained at 405 µm ± 78 µm 
after 7 days. This was due to AhR inhibition, 
because proliferation of AhR­deficient neuro­
spheres was not affected by MNF treatment 
(Figure 1D,E). Effects of MNF on mNPC 
proliferation were confirmed by FACS analy­
ses for DNA content using propidium iodine 
staining (Figure 1F). As for hNPCs, we found 
a cell cycle distribution typical of proliferat­
ing cells in approximately 2.5% of all cells. 
In the positive control (solvent plus growth 
factors), 56.1% ± 4.6% of these cells were in 
G0/G1­phase, 38.1% ± 4.3% were in S­phase, 
and 5.8% ± 0.4% cells were in G2/M­phase 
after 48 hr of exposure. 3­MC–treated cells 
showed a similar distribution. However, MNF 
treatment reduced the number of cells in 
G2/M­phase to 2.0% ± 0.4%, whereas the 
distribution of cells in G0/G1­ and S­phase 
remained relatively constant at 51.8% ± 0.2% 
and 46.3% ± 0.4%, respectively.
Neural cell migration is affected by AhR 
stimulation in mNPCs but not hNPCs. 
Next, we investigated whether 3­MC, B(a)P,   
TCDD, or MNF influences hNPC and 
mNPC migration. We exposed differentiating 
neurospheres to 1 and 10 µM 3­MC, 10 µM 
B(a)P, 1 nM TCDD, 0.1 µM MNF, or 1 µM 
MNF for 48 hr; 1 µM MeHgCl served as a 
positive control for inhibition of migration 
(Moors et al. 2009). Independent of exposures, 
all human neurospheres adhered to the PDL/
laminin matrix and migrated radially out of 
the sphere with an average migration distance 
of 739 µm ± 61 µm after 48 hr (Figure 2A,C). 
This was verified using hNPCs from a second 
individual (data not shown).
In contrast to the results in hNPCs, AhR 
activation reduced migration distance in wild­
type mNPCs by 16% ± 5% (1 µM 3­MC), 
21% ± 13% (10 µM 3­MC), and 32% ± 10% 
[10 µM B(a)P] compared with solvent con­
trols, whereas migration was comparable with 
controls after exposure to the AhR antagonist 
MNF (Figure 2B,D). This effect can be attrib­
uted to AhR activation because migration of 
AhR­deficient neurospheres was not disturbed 
Figure 1. MNF inhibits proliferation of mNPCs (D–F) but not hNPCs (A–C). Abbreviations: NC, negative con-
trol (0.1% DMSO without added growth factors); PC, positive control (0.1% DMSO plus 20 ng/mL each of EGF 
and FGF); WT, wild type. After exposure of NPCs to 3-MC (1 μM and 10 μM), TCDD (0.001 μM), or MNF (1 μM) 
for 7 (mNPCs) or 14 (hNPCs) days, sphere diameters and mitochondrial reductase activities of human (A, B) 
and WT and AhR-KO mouse (D, E) neuro  spheres were measured; results are reported as percentages of 
corresponding measure  ments in PCs. The results for each end point were plotted in separate x,y-diagrams, 
and the gradient of the linear regression curve was assessed; data represent the mean gradient ± SEM 
of two (AhR-KO) to four independent experiments (5–6 spheres/exposure). Cell cycle phase distributions 
(values are shown within or above bars) of dissociated, fixed, and propidium iodine–stained hNPCs (C) and 
mNPCs (F) analyzed by FACS. Data represent the mean ± SEM of three independent experiments after 48-hr 
exposure to 10 μM 3-MC or 1 μM MNF. 
*p < 0.05 compared with PCs.
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by 3­MC or B(a)P (Figure 2D). Interestingly, 
TCDD did not disrupt wild­type mNPC 
migration despite AhR activation (Figure 2D). 
This might be due to the fact that, in con­
trast to 3­MC and B(a)P, TCDD is hardly 
metabolized and thus does not produce   
reactive intermediates.
AhR-dependent gene transcription. AhR­
dependent gene transcription is inducible 
only in mNPCs, and not in hNPCs because 
of low abundance of AhR and ARNT tran­
scripts and absence of AhR protein in human 
cells. Because 3­MC, B(a)P, and MNF did 
not influence hNPC viability, proliferation, 
or migration but did modulate proliferation 
or migration of mNPCs, we determined AhR 
and ARNT mRNA expression after exposure 
to these compounds in hNPCs and mNPCs 
under proliferating and differentiating condi­
tions. AhR and ARNT mRNAs were expressed 
at very low copy numbers in hNPCs (0.6–2.5 
and 13/1,000 copies β­actin, respectively) 
and higher copy numbers in mNPCs (20–63 
and 716–1,045/1,000 copies β­actin, respec­
tively) (Table 1). In addition, CYP1A1 expres­
sion was undetectable in untreated hNPCs. 
That β­actin was in this case valid to use as 
a house  keeping gene was demonstrated by 
normalization of proliferating versus differ­
entiating NPCs to three additional house­
keeping genes [RPL27, RPL30, OAZ1; see 
Supplemental Material, Figure 2 (doi:10.1289/
ehp.0901545)]. Expression of the AhR target 
genes AhRR, CYP1A1, CYP1B1, and c-myc 
was not significantly induced by 10 µM 3­MC 
after 6, 12, 24, and 48 hr of differentiation in 
hNPCs (Figure 3A). We obtained comparable 
results for hNPCs from a second individual 
after 6 hr of treatment (data not shown). In 
contrast, 6 hr of exposure to 10 µM 3­MC 
significantly induced Cyp1a1 and Cyp1b1 
mRNA in wild­type mNPCs to levels 6.6 ± 
1.7 and 2.5 ± 0.25 times higher than con­
trols, respectively (Figure 3C). Although 1 nM 
TCDD did not disturb neural migration, it 
induced AhR signaling in wild­type mNPCs, 
increasing Cyp1a1 expression 21 times relative 
to controls (Figure 3C, inset).
Comparison of mRNA expression lev­
els between hNPCs and mNPCs showed 
that genes belonging to the AhR machin­
ery and AhR­dependent genes were gener­
ally expressed in higher copy numbers/1,000 
copies β­actin in mNPCs than in hNPCs 
(Table 1). Lack of AhR protein in hNPCs 
was confirmed by Western blot (Figure 3B). 
These results demonstrate that AhR signaling 
pathway gene products mediate the effects of 
the AhR agonists 3­MC and B(a)P and the 
AhR antagonist MNF on proliferation and 
migration in mNPCs, because AhR­deficient 
mNPCs are protected against these effects 
(Figure 3C, inset).
Discussion
The development of cell­based, non  animal test­
ing strategies for hazard assessment of chemicals 
is currently one of the most important tasks in 
toxicological research. In this regard, it is most 
important to choose appropriate model systems 
that are truly predictive for humans (Krewski 
et al. 2009; National Research Council 2007). 
Human tumor cell lines that are easily acces­
sible in large quantities bear the restriction that 
they do not represent cellular metabolism and 
signal transduction of normal cells. In con­
trast, primary cells are often obtained as ex vivo 
cultures from rodents. Such primary cultures 
are regarded as superior to tumor­derived 
cells. However, species­specific differences 
limit their application. One example of how 
rodent primary cells can indeed mis  classify 
hazards for humans is provided by this study, 
which shows mouse­derived primary cells 
to be more susceptible to AhR modulation 
than their human counter  parts. With regard 
to chemical testing, it is critical to be aware 
of such differences in order to avoid over­ or 
under  estimating hazards that chemicals pose 
to humans, and thereby protect human health 
and allow industry production and develop­
ment of chemicals at the same time.
Figure 2. AhR agonists shorten wild-type mNPC but not hNPC migration. hNPCs (A and C) and wild-type (B 
and D) and AhR-KO (D) mNPCs were exposed to 3-MC, B(a)P, TCDD, MNF, or MeHgCl (PC) during differen-
tiation for 48 hr. Migration distance from the edge of the sphere to the furthest outgrowth was measured. 
Data represent means ± SEs of two (AhR-KO) to five independent experiments (5–8 spheres/exposure). 
Bar = 500 μm. 
*p < 0.05 compared with 0.1% DMSO.
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Table 1. Comparison of human and mouse mRNA copy numbers/1,000 copies of β-actin in proliferating 
and 24-hr differentiating NPCs.a
Human Mouse Mouse:human ratio
Gene Prolif Diff Prolif Diff Prolif Diff
AhR 2.45 0.62 20.08 63.21 8.19 102.12
ARNT 12.95 13.55 716.26 1045.07 55.31 77.13
AhRR 0.94 0.61 79.21 387.55 84.24 638.85
CYP1A1 < 0.001 < 0.001 18.63 31.64 ND ND
CYP1B1 0.01 0.06 146.24 834.91 16407.23 14990.75
C-MYC 5559.59 3017.13 14835.55 15967.72 2.67 5.29
Abbreviations: Diff, differentiating; ND, not detectable; Prolif, proliferating.
aData represent at least three independent experiments. The mouse:human ratio is shown to compare human and 
mouse mRNA expression levels.Species-specific AhR-mediated developmental toxicity
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Specifically, in this study we discovered 
that proliferation of hNPCs was not affected 
by AhR agonists (3­MC, TCDD) or the AhR 
antagonist MNF (Figure 1A–C), whereas pro­
liferation of wild­type mNPCs was completely 
blocked by AhR antagonism (Figure 1D–F). 
Results of the proliferation analysis in hNPCs 
are in contrast to previous findings obtained 
in human liver or neuro  blastoma tumor cells 
that showed exogenous AhR activation by 
TCDD or other AhR ligands to inhibit cell 
proliferation and induce cell cycle arrest (Jin 
et al. 2004; Marlowe and Puga 2005). In con­
trast, high AhR content has been reported 
to promote proliferation in a human MCF 
breast cancer cell line that was blocked by 
the AhR antagonist MNF or selective AhR 
knockdown via small interfering RNA (Wong 
et al. 2009). In human umbilical vascular 
endothelial cells, AhR activation by 3­MC 
also exerted anti  proliferative effects, as in the 
tumor cell lines (Pang et al. 2008). These data 
demonstrate that effects of AhR activation on 
cell cycle progression versus cell cycle arrest 
vary among different cell types, as well as 
between tumor and non  tumor cells.
In contrast to hNPCs, proliferation of 
mNPCs was completely blocked by MNF 
(Figure 1D–F). Reiners et al. (1999) reported 
that cell proliferation was also inhibited in 
the murine hepatoma cell line 1c1c7 by fla­
vone and α­naphthoflavone treatment and in 
AhR­KO cells. Moreover, mouse embryonic 
fibroblasts from AhR­KO mice grew more 
slowly than did wild­type cells (Elizondo et al. 
2000). In contrast, AhR­KO animals show 
accelerated proliferation in different organs, 
such as skin, hair follicles, and liver blood 
vessels. Thus, as in humans, AhR effects on 
proliferation in rodent cells are also cell type 
dependent, and as our data indicate, cell type 
specificity is not consistent among different 
species.
Besides progenitor cell proliferation, 
migration is another essential process in brain 
develop  ment. To address the role of the AhR 
in this process, we employed the neurosphere 
migration assay (Moors et al. 2007). AhR 
modulation by 3­MC, B(a)P, TCDD, or MNF 
did not affect hNPC migration (Figure 2A,C). 
These results were in contrast to the findings 
of two previous studies of human tumor cells 
that showed increased motility and migra­
tion of MCF­7 cells after TCDD and 3­MC 
treatment based on a scratch assay (Diry et al. 
2006) and a transwell migration assay (Seifert 
et al. 2009). In contrast, we showed that AhR 
stimulation reduced migration of mNPCs 
(Figure 2B,D). This is supported by an earlier 
in vivo study in which prenatal exposure to the 
AhR ligand 7,12­dimethylbenz[a]anthracene 
disrupted cerebellar cytoarchitecture in rats 
(Kellen et al. 1976). Conversely, immortalized 
mouse mammary fibro  blasts from AhR­null 
mice had decreased migration capacities in 
culture and inhibition of signaling pathways 
that regu  late cell migration, including focal 
adhesion kinase and mitogen­activated protein 
kinase ERK1 (extracellular­signal regulated 
kinase­1) (Mulero­Navarro et al. 2005). That 
ERK­dependent pathways are also necessary 
for normal migration of hNPCs was recently 
shown by our group (Moors et al. 2007). 
However, AhR does not seem to determine 
ERK­dependent migration in hNPCs, because 
migration distance did not change in the 
presence of AhR modulators (Figure 2A,C) 
but was impaired by ERK inhibition (Moors 
et al. 2007). Taken together, existing data on 
AhR­dependent migration imply that, as for 
prolifera  tion, modulation of cell migration dif­
fers among cell types and species.
To address the underlying reason for 
the observed species­specific differences in 
response to AhR modulation between hNPCs 
and mNPCs, we quantified copy numbers 
of genes that belong to the AhR machinery 
as well as genes that are AhR regulated. Both 
hNPCs and mNPCs express AhR, ARNT, 
AhRR, CYP1B1, and c-Myc (Figure 3A,C). 
However, AhR and ARNT copy numbers were 
close to detection limit in hNPCs (and 8–100 
times lower than in mNPCs), and hAhR 
protein was not detectable by Western blot; 
consequently, only mNPCs expressed quan­
tifiable amounts of Cyp1a1 and responded to 
3­MC treatment with a time­related induction 
of Cyp1a1 and Cyp1b1 mRNA (Figure 3). 
Moreover, low human AhR ligand affin­
ity, which is approximately 10 times lower 
than C57/BL6 mouse AhR­ligand attraction 
(Harper et al. 1988), has been attributed to 
an amino acid substitution in the human AhR 
ligand­binding domain (Ema et al. 1994). 
This mutation is also responsible for divergent 
toxic potencies of TCDD between responsive 
Figure 3. Induction of mRNA expression of the indicated genes in hNPCs (A) and mNPCs (C) analyzed 6, 12, 
24, or 48 hr after treatment with 10 μM 3-MC under differentiating conditions. The inset in C shows Cyp1a1 
expression 6 hr after 1-nM TCDD or 10-μM 3-MC exposure in wild-type (WT) and AhR-KO mNPCs. Copy 
numbers of the respective genes were normalized to β-actin after and are expressed as relative induction 
compared with vehicle control (0.1% DMSO); data are mean ± SEM of two (AhR-KO) to four independent 
experiments; note the different y-axis scales in A and C. (B) hNPC lysates (40 μg protein/lane) analyzed for 
AhR expression by Western blot using an AhR-specific antibody and HepG2 cell lysates (10 μg protein/lane) 
as the positive control. A GAPDH-specific antibody was used as a loading control; a representative example 
is shown. 
*p < 0.05 compared with vehicle control.
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C57/BL6 and non  responsive DBA mouse 
strains (Ema et al. 1994). The irresponsive­
ness of hNPCs toward AhR modulation was 
hence likely due to very low AhR expression 
combined with a human low­affinity recep­
tor for ligand binding. Because several poly­
morphisms have been identified in the human 
AhR gene, inter  individual differences in ligand 
responsiveness between hNPCs from different 
donors cannot be excluded. However, even 
though single AhR polymorphisms (e.g., at 
codon 517 or 570) found in people of African 
descent were under suspicion to affect the 
expression of single genes such as CYP1A1, 
it is widely accepted that none of the AhR 
polymorphisms described so far is of any func­
tional consequence regarding the overall out­
come of AhR response (Connor and Aylward 
2009; Harper et al. 2002).
Species differences similar to those 
reported here were observed in a compara­
tive study of human and mouse palate organ 
cultures (Abbott et al. 1999). This earlier work 
was driven by the facts that TCDD induces 
cleft palate in mouse embryos and that the risk 
for humans to develop such malformations 
upon in utero exposure to TCDD or related 
compounds was not known. Abbott et al. 
(1999) concluded that it seems highly unlikely 
that human embryos are exposed to sufficient 
amounts of TCDD to cause interruption of 
palatal differentiation because human palate 
organ cultures expressed several hundred times 
less AhR mRNA than did the mouse cultures, 
and human palates required 200 times more 
TCDD to produce a cleft palate in vitro than 
did the respective mouse model. Our results 
support those findings in a different organ 
system, the developing brain, and suggest that 
studies on AhR­dependent DNT in C57/BL6 
mice in vivo over  estimate the risk of distur­
bances of human brain development resulting 
from AhR activation. Our data also imply that 
the use of toxic equivalency factors, which cor­
respond to the relative potency of a chemical 
to generate AhR­mediated effects compared 
with TCDD, based on data derived from 
rodents for risk assessment of POPs may not 
necessarily be useful for humans.
How can the epidemiological evidence for 
POP­related DNT in humans be explained if 
the AhR is not involved in chemically induced 
DNT? Kodavanti (2005) comprehensively 
reviewed three alternative mechanisms for 
how POPs might interfere with human brain 
develop  ment. First, POP­induced changes in 
neuro  transmitters such as dopamine or sero­
tonin could affect learning, memory, and other 
functions. Because these end points extend 
beyond the basic processes of brain develop­
ment, the basic “neurosphere assay” (Breier 
et al. 2009) cannot detect such changes. 
Second, PCBs were found to alter intra  cellular 
phospho  kinase C (PKC) signaling and Ca2+ 
homeo  stasis in rodents. Because PKC mod­
ulation by the inhibitor BisI (bisindolylma­
leimide I) or the stimulator PMA (phorbol 
12­myristate 13­acetate) causes inhibition and 
stimulation of hNPC migration, respectively 
(Moors et al. 2007), it is unlikely that the POPs 
used in this study affected PKC signaling.   
Third, effects on thyroid hormone (TH) bal­
ance might contribute to POP­induced DNT. 
Some POPs can elicit direct biological effects 
on target organs such as the brain by inter­
fering with cellular TH signaling in vivo and 
in vitro (Fritsche et al. 2005; Schreiber et al. 
2010; Zoeller and Crofton 2000). Because 
the neurosphere assay is able to detect endo­
crine disruption of TH signaling by PCBs 
and polybrominated diphenyl ethers (Fritsche 
et al. 2005; Schreiber et al. 2010), this mecha­
nism is hence unlikely to be involved in AhR­
independent DNT of “classical” AhR ligands 
such as 3­MC or TCDD in humans. The 
most likely mechanism through which POPs 
interfere with human brain development is 
via systemic effects on TH homeostasis result­
ing from direct effects on the thyroid gland 
and decreased synthesis of TH, reduced blood 
TH levels secondary to enhanced TH metabo­
lism, or displacement of natural ligand (thy­
roxine) binding to the TH plasma transport 
protein transthyretin. Evidence that TCDD 
also affects systemic TH balance in humans 
was reported by Baccarelli et al. (2008), who 
found that maternal exposure in the highly 
TCDD­exposed Seveso cohort was associ­
ated with effects on neo  natal thyroid function 
(Baccarelli et al. 2008). However, we cannot 
exclude the possibility that AhR expression 
in fetal brains increases with gestational age, 
resulting in AhR­mediated toxicity of POPs in 
NPCs at later gestational stages.
In summary, we show that, in contrast to 
mNPCs, hNPCs are protected against PAH­
induced DNT and that this difference may be 
explained by the absence of AhR in hNPCs. 
An accumulating body of evidence now indi­
cates that human AhR signaling is less opera­
tive than AhR function in most laboratory 
animals. This knowledge should be taken into 
account for risk assessment of TCDD and 
related xenobiotics in humans.
RefeRences
Abbott BD, Held GA, Wood CR, Buckalew AR, Brown JG, 
Schmid J. 1999. AhR, ARNT, and CYP1A1 mRNA quantita-
tion in cultured human embryonic palates exposed to TCDD 
and comparison with mouse palate in vivo and in culture. 
Toxicol Sci 47:62–75.
Baccarelli A, Giacomini SM, Corbetta C, Landi MT, Bonzini M, 
Consonni D, et al. 2008. Neonatal thyroid function in Seveso 
25 years after maternal exposure to dioxin. PLoS Med 5:e161; 
doi:10.1371/journal.pmed.0050161 [Online 29 July 2008].
Bard JL, Kaufman MH, Dubreuil C, Brune RM, Burger A, 
Baldock RA, et al. 1998. An internet-accessible database 
of mouse developmental anatomy based on a systematic 
nomenclature. Mech Dev 74:111–120.
Batty GD, Der G, Deary IJ. 2006. Effect of maternal smoking 
during pregnancy on offspring’s cognitive ability: empirical 
evidence for complete confounding in the US national longi-
tudinal survey of youth. Pediatrics 118:943–950.
Breier JM, Gassmann K, Kayser R, Stegeman H, De Groot D, 
Fritsche E, et al. 2009. Neural progenitor cells as models for 
high-throughput screens of developmental neuro  toxicity: 
state of the science. Neurotoxicol Teratol 32(1):4–15.
Connor KT, Aylward LL. 2009. Human response to dioxin: aryl 
hydrocarbon receptor (AhR) molecular structure, function, 
and dose-response data for enzyme induction indicate an 
impaired human AhR. J Toxicol Environ Health B 9:147–171.
Diry M, Tomkiewicz C, Koehle C, Coumoul X, Bock KW, 
Barouki R, et al. 2006. Activation of the dioxin/aryl hydro-
carbon receptor (AhR) modulates cell plasticity through a 
JNK-dependent mechanism. Oncogene 25:5570–5574.
Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, 
Fornace AJ, Lee KS, et al. 2000. Altered cell cycle control 
at the G(2)/M phases in aryl hydrocarbon receptor-null 
embryo fibroblast. Mol Pharmacol 57:1056–1063.
Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, Ikawa S, et al. 
1994. Dioxin binding activities of polymorphic forms of 
mouse and human arylhydrocarbon receptors. J Biol Chem 
269:27337–27343.
Fergusson DM, Woodward LJ, Horwood LJ. 1998. Maternal 
smoking during pregnancy and psychiatric adjustment in 
late adolescence. Arch Gen Psychiatry 55:721–727.
Fried PA, Watkinson B, Gray R. 1998. Differential effects on cogni-
tive functioning in 9- to 12-year olds prenatally exposed to 
cigarettes and marihuana. Neurotoxicol Teratol 20:293–306.
Fritsche E, Cline JE, Nguyen NH, Scanlan TS, Abel J. 2005. 
Polychlorinated biphenyls disturb differentiation of nor-
mal human neural progenitor cells: clue for involvement 
of thyroid hormone receptors. Environ Health Perspect 
113:871–876.
Fritsche E, Schäfer C, Calles C, Bernsmann T, Bernshausen T, 
Wurm M, et al. 2007. Lightening up the UV response by 
identification of the arylhydrocarbon receptor as a cyto-
plasmatic target for ultraviolet B irradiation. Proc Nat 
Acad Sci USA 104:8851–8856.
Fujisawa-Sehara A, Sogawa K, Yamane M, Fujii-Kuriyama Y. 
1987. Characterization of xenobiotic responsive elements 
upstream from the drug-metabolizing cytochrome P-450c 
gene: a similarity to glucocorticoid regulatory elements. 
Nucleic Acids Res 15:4179–4191.
Gasiewicz TA, Bauman PA. 1987. Heterogeneity of the rat hepatic 
Ah receptor and evidence for transformation in vitro and 
in vivo. J Biol Chem 262:2116–2120.
Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity 
of industrial chemicals. Lancet 368:2167–2178.
Harper PA, Golas CL, Okey AB. 1988. Characterization of the Ah 
receptor and aryl hydrocarbon hydroxylase induction by 
2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene 
in the human A431 squamous cell carcinoma line. Cancer 
Res 48:2388–2395.
Harper PA, Wong JMY, Lam MSM, Okey AB. 2002. Polymorphisms 
in the human AH receptor. Chem Biol Interact 141:161–187.
Hays WL. 1994. Statistics. 5th ed. Orlando, FL:Harcourt Brace.
Henshel DS, Martin JW, DeWitt JC. 1997. Brain asymmetry as a 
potential biomarker for developmental TCDD intoxication: a 
dose-response study. Environ Health Perspect 105:718–725.
Hill A, Howard CV, Strahle U, Cossins A. 2003. Neuro-
developmental defects in zebrafish (Danio rerio) at environ-
mentally relevant dioxin (TCDD) concentrations. Toxicol Sci 
76:392–399.
Jacobson JL, Jacobson SW. 1997. Evidence for PCBs as neuro-
developmental toxicants in humans. Neurotoxicology 
18:415–424.
Jin DQ, Jung JW, Lee YS, Kim JA. 2004. 2,3,7,8-Tetrachloro-
dibenzo-p-dioxin inhibits cell proliferation through aryl-
hydrocarbon receptor-mediated G1 arrest in SK-N-SH 
human neuronal cells. Neurosci Lett 363:69–72.
Kakeyama M, Tohyama C. 2003. Developmental neurotoxicity of 
dioxin and its related compounds. Ind Health 41:215–230.
Kellen JA, Kolin A, Fletch AL. 1976. Cerebellar dysgenesis in rats 
by diaplacental effects of 7,12-dimethylbenz[a]anthracene. 
J Natl Cancer Inst 56:1063–1067.
Kodavanti PR. 2005. Neurotoxicity of persistent organic pollut-
ants: possible mode(s) of action and further considera  tions. 
Dose Response 3:273–305.
Krewski D, Andersen ME, Mantus E, Zeise L. 2009. Toxicity 
testing in the 21st century: implications for human health 
risk assessment. Risk Anal 29:474–479.
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene 
expression data using real-time quantitative PCR and the 
2−ΔΔCT method. Methods 25:402–408.Species-specific AhR-mediated developmental toxicity
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 11 | November 2010  1577
Marlowe JL, Puga A. 2005. Aryl hydrocarbon receptor, cell cycle 
regulation, toxicity, and tumorigenesis. J Cell Biochem 
96:1174–1184.
Moors M, Cline JE, Abel J, Fritsche E. 2007. ERK-dependent and 
-independent pathways trigger human neural progenitor 
cell migration. Toxicol Appl Pharmacol 221:57–67.
Moors M, Rockel TD, Abel J, Cline JE, Gassmann K, Schreiber T, 
et al. 2009. Human neurospheres as three-dimensional 
cellular systems for developmental neuro  toxicity testing. 
Environ Health Perspect 117:1131–1138.
Mulero-Navarro S, Pozo-Guisado E, Perez-Mancera PA, Varez-
Barrientos A, Catalina-Fernandez I, Hernandez-Nieto E, 
et al. 2005. Immortalized mouse mammary fibroblasts 
lacking dioxin receptor have impaired tumorigenicity in 
a subcutaneous mouse xenograft model. J Biol Chem 
280:28731–28741.
National Research Council. 2007. Toxicity Testing in the 21st 
Century: A Vision and a Strategy. Washington, DC:National 
Academy Press.
Olds DL, Henderson CR Jr, Tatelbaum R. 1994. Intellectual 
impairment in children of women who smoke cigarettes 
during pregnancy. Pediatrics 93:221–227.
Pang PH, Lin YH, Lee YH, Hou HH, Hsu SP, Juan SH. 2008. 
Molecular mechanisms of p21 and p27 induction by 
3-methyl  cholanthrene, an aryl-hydrocarbon receptor ago-
nist, involved in antiproliferation of human umbilical vas-
cular endothelial cells. J Cell Physiol 215:161–171.
Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ, 
Weisglas-Kuperus N. 1999. Effects of environmental expo-
sure to polychlorinated biphenyls and dioxins on cognitive 
abilities in Dutch children at 42 months of age. J Pediatr 
134:33–41.
Polanska K, Hanke W, Sobala W, Brzeznicki S, Ligocka D. 2009. 
Exposure of smoking pregnant women to polycyclic aro-
matic hydrocarbons [in Polish]. Med Pr 60:103–108.
Qin H, Powell-Coffman JA. 2004. The Caenorhabditis elegans 
aryl hydrocarbon receptor, AHR-1, regulates neuronal 
development. Dev Biol 270:64–75.
Reiners JJ Jr, Clift R, Mathieu P. 1999. Suppression of cell cycle 
progression by flavonoids: dependence on the aryl hydro-
carbon receptor. Carcinogenesis 20:1561–1566.
Reyes H, Reisz-Porszasz S, Hankinson O. 1992. Identification 
of the Ah receptor nuclear translocator protein (Arnt) as 
a component of the DNA binding form of the Ah receptor. 
Science 256:1193–1195.
Rodgman A, Smith CJ, Perfetti TA. 2000. The composition of 
cigarette smoke: a retrospective, with emphasis on poly-
cyclic components. Hum Exp Toxicol 19:573–595.
Rozen S, Skaletsky HJ. 2000. Primer3 on the WWW for general 
users and for biologist programmers. In: Bioinformatics 
Methods and Protocols: Methods in Molecular Biology 
(Krawetz S, Misener S, eds). Totowa, NJ:Humana Press, 
365–386.
Schreiber T, Gassmann K, Götz C, Hübenthal U, Moors M, 
Krause G, et al. 2010. Polybrominated diphenyl ethers 
induce developmental neurotoxicity in a human in vitro 
model: evidence for endocrine disruption. Environ Health 
Perpect 118:572–578. 
Seifert A, Rau S, Kullertz G, Fischer B, Santos AN. 2009. TCDD 
induces cell migration via NFATc1/ATX-signaling in MCF-7 
cells. Toxicol Lett 184:26–32.
Thapar A, Fowler T, Rice F, Scourfield J, van den BM, Thomas H, 
et al. 2003. Maternal smoking during pregnancy and atten-
tion deficit hyperactivity disorder symptoms in offspring. 
Am J Psychiatry 160:1985–1989.
Weissman MM, Warner V, Wickramaratne PJ, Kandel DB. 
1999. Maternal smoking during pregnancy and psycho-
pathology in offspring followed to adulthood. J Am Acad 
Child Adolesc Psychiatry 38:892–899.
Williamson MA, Gasiewicz TA, Opanashuk LA. 2005. Aryl hydro-
carbon receptor expression and activity in cerebellar 
granule neuroblasts: implications for developmental and 
dioxin neurotoxicity. Toxicol Sci 83:340–348. 
Wong PS, Li W, Vogel CF, Matsumura F. 2009. Characterization 
of MCF mammary epithelial cells overexpressing the 
arylhydrocarbon receptor (AhR). BMC Cancer 9:234; 
doi:10.1186/1471-2407-9-234 [Online 15 July 2009].
Wormley DD, Ramesh A, Hood DB. 2004. Environmental   
contaminant-mixture effects on CNS development, plastic-
ity, and behavior. Toxicol Appl Pharmacol 197:49–65.
Zoeller RT, Crofton KM. 2000. Thyroid hormone action in fetal 
brain development and potential for disruption by environ-
mental chemicals. Neurotoxicology 21:935–945.